Idoxuridine (5-iodo-2'-deoxyuridine) is a thymidine analogue which interferes with deoxyribonucleic acid (DNA) metabolism and inhibits herpes simplex virus multiplication. Its systemic use is limited by toxicity. Calabresi (1965) has recommended that it be used only for severe infections with DNA-containing viruses, or for malignant disease.
We report a newborn infant with severe herpes simplex infection; idoxuridine was used systemically with some evidence of effectiveness, though cessation of treatment was followed by relapse and death.
Case Report The course of the illness is shown in Fig. 1 . The patient, a girl, was born at term, and weighed 3-86 kg. The mother was primigravid and had never noted labial or genital herpes, though her husband had recurrent labial 'cold sores', the last episode being 6 months before the baby's birth.
The membranes ruptured spontaneously 81 hours before delivery. No herpetic genital lesions were noted before, during, or after labour. The liquor became offensive and the mother's temperature rose to 38. 8 C. The baby was born spontaneously after a 48-hour labour. She was slow to breathe and required resuscitation by endotracheal intubation and inflation. Respiration was established within 10 minutes. On the first day of life, she was irritable, with a serous eye discharge. Throat and eye swabs were bacteriologically sterile and she remained afebrile. Breast feeding was established.
On the 4th day she became febrile and sucked less well but was still alert and active: 5 crusting vesicles were now noticed on the neck, 2 intact vesicles on the chest, and 4 in the axilla. On the 7th day she was slightly breathless. The respiration rate was 60/min., the alae nasi were working, and there were a few fine crepitations at the lung bases. The liver was palpable 2 cm. below the costal margin. Chest x-ray showed patchy confluent opacities in the right lower zone (Fig.  2a) .
On the 10th day she was less well, with profuse, yellowish, mucopurulent nasal and pharyngeal secreReceived February 8, 1968. tions, and laboured, noisy breathing. The liver was palpable 5 cm., and the spleen 2 cm., below the costal margin. The vesicles were larger and a new group had appeared on the shoulder (Fig. 3) . Vesicle fluid and nose and throat swabs were collected for virus culture: herpes simplex virus was subsequently isolated from all of these (see Table III ). On the 11th day she was semicomatose, with head retraction. Examination of lumbar CSF showed a pleocytosis suggesting a virus infection (Table I) . A throat swab collected on the previous day grew 'coliform bacilli', and colistin, chloramphenicol, and prednisone were given.
On the 13th day the baby was severely ill and had two apnoeic attacks. Chest x-ray showed opacities in the right upper zone (Fig. 2b) , and an ECG showed abnormal QRS complexes with S-T elevation (Fig. 4a) . Following identification of the virus, it was decided to use idoxuridine which was given by an infusion through a scalp vein needle for 5 days, from the 13th to the 17th day (Table II) . Although it ran into the tissues for short periods there was no local reaction.
She was slightly better 48 hours after starting idoxuridine. No new vesicles had appeared and those present were resolving. By the 22nd day she was considerably improved, alert, hungry, and taking some bottle feeds. The x-ray appearances of the chest (Fig. 2c ) and the ECG appearances (Fig. 4b) had improved. The clinical improvement was gradual but definite, though at no time did she return to completely normal health and it was feared that there had already been irreversible brain damage.
On the 23rd day of life 2 new vesicles appeared on the right shoulder. 2 days later vesicles reappeared at the previous site on the left chest. Topical idoxuridine was applied to them, and also to a mild dry scaly rash on the face. A dose of 4-7 ml. y-globulin was given intramuscularly. On the 27th day she rapidly deteriorated with considerable respiratory distress. A second course of idoxuridine was started together with prednisone and colistin. She died the next day, aged 28 days, having received 250 mg. idoxuridine in the previous 12 hours.
When herpes simplex virus was isolated from the baby, the mother was examined for herpetic ulcers or vesicles. None were seen on her face, lips, mouth, vulva, or vagina (the cervix was not examined). The vaginal swab yielded herpes simplex virus. The mother was examined again 43 days post partum but no lesions were 377 Necropsy. This was performed 3 hours after death. Macroscopical abnormalities were confined to the skin and the lungs. Several small macules (up to 0 *3 cm. diameter) were present in the skin of the right shoulder and left chest. There was a rash of yellowish-brown papules (up to 0 1 cm. diameter) over the cheeks and chin. Approximately 10 ml. clear, dark yellow fluid were present in each pleural cavity. The pink-red lungs felt firm; scattered throughout all lobes there were yellowish-grey foci (up to 0 3 cm. diameter); at the surface these appeared as grey vesicles.
Histological examination revealed abnormalities in the skin, lungs, brain, and spinal cord.
Skin. Sections of the macules showed abnormal epithelial cells with large or double nuclei, and collections of inflammatory cells (lymphocytes, neutrophil polymorphs, histiocytes, and plasma cells).
Lungs. Sections showed foci of necrosis each affecting approximately 12-20 alveoli, which contained eosinophilic debris and many Gram-positive cocci and Gram-negative bacilli. There was little inflammatory response to these foci. Throughout the lungs, alveolar septa were broadened and contained many inflammatory cells, including lymphocytes, histiocytes, plasma cells, Table I .
A virus of herpes simplex morphology was seen in vesicle fluid taken on the 11th day and examined by electron microscopy. A smear taken from vesicle fluid on the 13th day examined by light microscopy suggested a lesion of viral aetiology though no inclusion bodies were seen.
Virus isolation. Conventional methods of tissue culture were used for virus isolation. Some attempts were unsuccessful because of overgrowth by antibiotic resistant bacteria. These have been omitted from the results, shown in Table III. Virus serology. Hexpes simplex complement-fixation titres (CFT) against a standard antigen, and neutralizing titres against the virus grown from the baby, were estimated on sera from the baby and her parents. Neutralizing tests were done in human amnion tissue culture. Titres were similar in samples of serum from mother and baby; neither showed any significant rise (Table  IV) . From this it seems likely that the mateinal infection had not been recent and that the baby's antibodies were passively acquired.
Discussion
This case demonstrates some features of systemic herpes simplex infection of the newborn which are discussed elsewhere (MacCallum and Partridge, 1968) .
Isolation of the virus from the mother's vagina, the prolonged interval between delivery and rupture of the membranes, and isolation of the virus from the baby's respiratory tract, suggest that the route of infection was from the liquor into the baby's air passages either before birth or during delivery. Resuscitation by intubation and positive pressure may have contributed to this. It is of interest that virus was recovered from the mother's vagina in the absence of overt signs of herpetic infection, but cervical lesions may have been missed.
Systemic idoxuridine was used with reluctance because of its reported toxicity. However, the white cell and platelet counts remained unaffected, the two aminotransferase estimations were normal, and there were no observed side-effects. In this case no comment can be made about possible long-term side-effects which might be expected to occur when a drug that interferes with DNA metabolism is used.
The main evidence that idoxuridine improved the baby's condition was clinical. The baby was moribund before treatment, improvement was noted within 48 hours, and was sustained until 11 days after treatment began. The skin lesions regressed and virus was not subsequently isolated from the throat. The improvement in the chest x-ray provided further evidence. The ECG changes were thought to be in keeping with pericardial involvement and the return to normal accompanied clinical signs of improvement. No lesions were seen in the heart at necropsy and virus was not isolated from the pericardial fluid. This suggests that either there had been no virus infection of the heart, or treatment had completely eradicated it. There are few references to cardiac involvement in disseminated herpes simplex infection of the newborn. The case of Bernard et al. (1961) showed ECG changes with atrioventricular dissociation, and there were histological lesions in the myocardium and in the bundle of His. The virus was cultured from the heart in the absence of recognizable lesions in the case of Witzleben and Driscoll (1965) .
This phase of initial recovery, however, was followed by the reappearance of skin vesicles 6 days after treatment ceased. The second infusion of idoxuridine was withheld until late in the terminal relapse because of fear of toxicity. It was infused in the last 12 hours of life only. No virus was obtained from post-mortem material (brain, liver, and pleural and pericardial fluid) collected 3 hours after death. As the herpes simplex virus is usually easy to isolate, as it was before treatment in this case, these negative virus cultures may well be significant.
The part played in this illness by secondary infection with antibiotic resistant bacteria is difficult to assess. These were grown from throat and nose swabs, overgrew tissue cultures for virus isolation, were isolated at necropsy, and were seen in postmortem lung sections in large numbers. These findings suggest that the bacterial infection was contributory and that antibiotics should perhaps have been used for a longer period.
If idoxuridine were used again for this condition, which has such a poor prognosis, a different regimen might be more effective, either using larger doses, or prolonging therapy with doses spaced at intervals. Summary A newborn infant developed systemic herpes simplex infection. Skin vesicles appeared on the 4th day. The diagnosis was confirmed on the 13th day and intravenous idoxuridine started. A total of 580 mg./kg. was given over 5 days, with clinical evidence of improvement. A relapse occurred at 23 days and the baby died aged 28 days. The postmortem findings are described. Further trial of idoxuridine in neonatal systemic herpes simplex is suggested.
